ClinTec 'on track' with growth strategy as new offices open in Spain
ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.
ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.
Xellia Pharmaceuticals has started building a stability and release-testing unit at its API facility in Budapest, Hungary that is designed to support increased output.
A recent study of clinical drug development success rates found that biomarker-enabled drug programs are three times more likely to reach approval.
As more CROs look to divest in-house clinical trial technologies, Bioclinica has released a new Clinical Trial Management System (CTMS) sized specifically for smaller organizations.
Amulet Capital Partners has bought SynteractHCR in its first acquisition in the contract research sector.
The US FDA has voted in favour of two combination type 2 diabetes drugs putting Novo Nordisk and Sanofi head-to-head in a crowded market.